Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors

Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of
Directors
Company's Board Expanded to Seven Members

DALLAS, April 10, /PRNewswire-FirstCall/ -- Crdentia Corp.
(OTC Bulletin Board: CRDT), a leading healthcare staffing company, today said
that its Board of Directors has elected David Jenkins and Raymond (Jay) Dunn
to its Board of Directors, effective immediately. This announcement expands
the Company's Board of Directors to seven members.
John Kaiser, Crdentia's President and Chief Executive Officer, said, "I am
delighted David and Jay have joined Crdentia's Board of Directors. Each has
tremendous depth of knowledge, healthcare expertise and public company
experience that now can accrue to the benefit of Crdentia. With this
announcement, the strength of our board is further enhanced, and we look
forward to contributions from David and Jay as we continue our efforts to
execute our strategic initiatives to improve Crdentia's operations and
profitably grow our business."
Mr. Jenkins is currently the managing member and general partner of FatBoy
Capital, LLC, a shareholder of Crdentia. In addition, Mr. Jenkins is also a
Director of EP MedSystems, Inc. (Nasdaq: EPMD), a medical technology company
that develops, manufactures and markets cardiac rhythm management and
electrophysiology products, which are used to diagnose, monitor, visualize and
treat irregular heartbeats known as arrhythmias. EP MedSystems, Inc. recently
announced an agreement to be acquired by St. Jude's Medical, Inc. Mr. Jenkins
has also served as President and a director of Transneuronix, Inc., a
privately-held company engaged in the development of neuromuscular stimulation
devices, until its sale to Medtronic Inc. in 2005. He is currently a director
of Inset Technologies, Inc. and Catheter Robotics, Inc., both of which are
privately held medical device companies.
Mr. Dunn is co-founder and Managing Director of the Latin Healthcare Fund
(LHF), a shareholder of Crdentia, and Healthcare Investments International LLC
(HII), which are US-based private equity investment groups that invests in
healthcare companies. LHF and HII are affiliates of ACON Investments LLC, to
identify healthcare investment opportunities in the U.S. Mr. Dunn also served
on the Boards of Farmacias Ahumada, the largest pharmacy chain in Latin
America and publicly traded in Chile; and Integramedica, the largest
outpatient services company in Chile. Prior to LHF and HII, Mr. Dunn was
Senior Investment Officer at Global Environment Fund where he managed the
investment program for Latin America and served on company boards in
Argentina, Chile, Peru and Colombia. He also sourced and analyzed investment
opportunities in Eastern Europe and the Middle East. Mr. Dunn started his
career with Brown Brothers Harriman & Co. as a banking officer in the Trade
and Commodity Finance Group.
About Crdentia Corp.
Crdentia Corp., one of the nation's leading providers of healthcare
staffing solutions, is focused on recruiting talented national and
international healthcare professionals to meet the ever-increasing employment
needs of over 2,300 clients. Crdentia is one of the few companies that can
provide quality temporary staff for all healthcare industry positions
including local nurses, travel nurses, allied health, locum tenens and home
care professionals. For more information, visit http://www.crdentia.com.
Forward Looking Statements
Statements contained in this release that are not historical facts are
forward-looking statements that involve risks and uncertainties. Among the
important factors which could cause actual results to differ materially from
those in the forward-looking statements include, but are not limited to, those
discussed in "Risk Factors" in the Company's Forms 10-K, Forms 10-Q, and other
filings with the Securities and Exchange Commission. Such risk factors
include, but are not limited to, a limited operating history with no earnings;
reliance on the Company's management team, members of which have other
business interests; the ability to successfully implement the Company's
business plan; the ability to continue as a going concern; the ability to fund
the Company's business and acquisition strategy; the growth of the temporary
healthcare professional staffing business; difficulty in managing operations
of acquired businesses; uncertainty in government regulation of the healthcare
industry; and the limited public market for the Company's common stock. The
actual results that the Company achieves may differ materially from any
forward-looking statements due to such risks and uncertainties. Crdentia
undertakes no obligation to revise or update publicly any forward-looking
statements for any reason.
Contact Crdentia Corp.
John Kaiser, CEO
Phone: 972.850.0780
Fax: 972.392.2722
jkaiser@crdentia.com

Jim TerBeest, CFO
Phone: 972.850.0780
Fax: 972.392.2722
jterbeest@crdentia.com

SOURCE Crdentia Corp.

John Kaiser, CEO, jkaiser@crdentia.com; or Jim TerBeest, CFO,
jterbeest@crdentia.com, both of Crdentia Corp., +1-972-850-0780, fax,
+1-972-392-2722